Med-Tech Firms Should Reduce Costs To Accommodate Payment and Delivery Reform – Health Affairs Study
This article was originally published in The Gray Sheet
Executive Summary
Health Affairs piece discusses opportunities and strategies for the medical device industry in a more cost-conscious environment.
You may also be interested in...
Benefit Designs Examined: Reference Pricing And Center-Of-Excellence Contracting
Reference pricing and contracting with centers-of-excellence are two relatively novel approaches that some employers and insurers are using to encourage employees to make more cost conscious decisions when choosing services.
Launch Of Pioneer ACOs Marks First Step Away From Fee-For-Service Payment
The transition begins: Thirty-two health provider groups have begun operating under a new Medicare payment system, with many more to follow. The move away from traditional fee-for-service payment has big implications for the way medical device firms do business.
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.